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1. Introduction 
The mechanism of the creatine kinase reaction has 
been shown to be random order, rapid equilibrium 
[l] . The specificity of creatine kinase (ATP:creatine 
N-phosphotransferase, EC 2.7.3.2) in relation to mag- 
nesium-nucleotide complexes was studied by James 
and Morrison [2] and the specificity in relation to 
guanidino substrates by McLaughlin and Cohn [3]. 
Clark and Warren [4] postulated that creatinine 
phosphate, the cyclic anhydride of creatine phos- 
phate (CP), could function as phosphoryl group donor 
in the creatine kinase reaction. Creatinine phosphate 
was identified by Zeile and Meyer [5] showing that 
the phosphoryl residue is bound at the exocyclic 
nitrogen atom. Spectroscopic data gave evidence for 
the double bond being located in the five-membered 
ring system of glycocyamidines [6-81. 
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Creatinine phosphate 
Broun [9,10] has described the reaction of creatinine 
phosphate with ADP catalysed by creatine kinase and 
mentioned that the compound would be suitable to 
function as donor of an energy-rich phosphate residue 
in cell metabolism. We investigated the properties of 
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creatinine phosphate as substrate and inhibitor for 
creatine kinase and alkaline phosphatase (EC 3.1.3.1). 
2. Methods and materials 
The kinetic of the reverse reaction of creatine 
kinase was determined by an optical enzyme assay 
with the aid of the hexokinase and glucose 6-phos- 
phate dehydrogenase reaction. In the auxiliary 
system the concentrations of the components for the 
coupled reactions were adjusted so that the auxiliary 
system did not limit the rate of the overall reaction. 
In a final volume of 3.5 ml the assay medium contain- 
ed 0.05 M triethanolamine buffer, pH 7.05; 3 mM 
D-glucose monohydrate; 2.58 mM MgC12 . 6 H2 0; 
0.154 mM NADP; 0.5 mM ADP trisodium salt (varied 
CP concentration) or 0.05-0.5 mM ADP trisodium 
salt (constant CP concentration); 11.44 mM CP diso- 
dium salt . 6 H2 0 (varied ADP concentration) or 1.43- 
17.16 mM CP disodium salt . 6 Hz0 (constant ADP 
concentration); 5.72 or 11.44 mM creatinine phos- 
phate disodium salt . 5 H2 0 (inhibition experiments); 
20 pg of hexokinase (about 2.8 U); 15 c1g of glucose 
6-phosphate dehydrogenase (about 2.1 U); 62.5 ng of 
creatine kinase (about 5.0. 10m3 U). The reaction was 
started by addition of creatine kinase and the change 
in absorbance at 334 nm was followed in intervals of 
30 set (d = 4 cm, T = 30°C). 
In order to investigate enzymatic hydrolysis 12.5 
/.fmoles of creatinine phosphate were incubated with 
0.1 mg of creatine kinase (0.05 M triethanolamine 
buffer, pH 7.05, T = 3O’C) or with 20-80 pg of 
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alkaline phosphatase (0.1 M glycine/NaOH buffer, 
pH 9.4, T = 20°C) for 30-l 20 min. Inorganic phos- 
phate was determined by the method of Berenblum 
and Chain [ 111 modified by Martin and Doty [ 121. 
After measuring the kinetics of highly purified 
creatine kinase of rabbit skeletal muscle (Boehringer 
Mannheim, Mannheim, Germany) we investigated the 
inhibition of creatine kinase activity in rabbit heart 
homogenates with regard to the possibility of an in 
vivo inhibition. 
Rabbit hearts were homogenized in 15 ml of 0.05 
M triethanolamine buffer, pH 7.05, by an Ultra- 
Turrax honogeniser. The homogenate was centri- 
fuged at 15 000 g for 30 min, in order to remove 
NADPH dehydrogenase. The supernatant was diluted 
1: 1000.0.02 ml of the diluted supernatant were used 
for each assay. For protein determination the method 
described by Lowry et al. [ 131 was used with bovine 
serum albumine as standard. 
Enzymes and coenzymes were purchased from 
Boehringer Mannheim, Mannheim, Germany. Creat- 
inine phosphate was a gift from Sanol-Arzneimittel 
Dr Schwarz GmbH, Monheim, Germany. 
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3. Results and discussion 
In assays with creatinine phosphate as substrate for 
creatine kinase no reaction was observed. Therefore, 
it is obvious that creatinine phosphate cannot be used 
by creatine kinase as donor of the phosphoryl group 
in order to accomplish ATP formation. The hypothesis 
of Clark and Warren [4] stating that in the forward 
reaction creatine and in the reverse reaction creatinine 
phosphate serve as substrates could not be verified. 
Furthermore, this result put in question the in vivo 
utilisation of creatinine phosphate as donor of an 
energy-rich phosphate group [9,10]. 
The rate of spontaneous hydrolysis of creatinine 
phosphate was not accelerated by the addition of 
creatine kinase at 30°C and pH 7.0 indicating that 
there was no phosphatase activity in the creatine 
kinase preparation in relation to creatinine phosphate. 
The kinetics of the creatine kinase reaction were 
determined as a function of the creatine phosphate 
concentration when the ADP concentration was held 
constant at 0.5 mM. In fig. 1 the experimental data of 
v. have been plotted in the double reciprocal 
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Fig. 1. Competitive inhibition of the initial velocity of the creatine kinase reaction by creatinine phosphate with creathe phos- 
phate as variable substrate. pH 7.05, T = 30°C ADP concentration 0.5 mM. (0) no added creatinine phosphate, (0) 5.72 mM, 
(a) 11.44 mM creatinine phosphate. (Means of three experiments.) 
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Lineweaver-Burk diagram. Addition of creatinine 
phosphate in two concentrations effected a compet- 
itive inhibition. When the ADP concentration was 
varied and the CP concentration held constant the 
kinetic data showed a noncompetitive inhibition by 
creatinine phosphate (fig. 2). A replot of the intercepts 
from Lineweaver-Burk diagram (fig. 1) versus the 
inhibitor concentration resulted in an apparent Ki 
= 5 . 10m3 (fig. 3). As creatinine phosphate acts as 
competitive inhibitor with respect to CP and as non- 
competitive inhibitor with respect to ADP it can be 
assumed that creatinine phosphate as an analog of CP 
competes with CP for the binding site at the enzyme 
not influencing the binding of ADP. A conversion of 
the central enzyme-MgADP-creatinine phosphate com- 
plex to an enzyme-MgATP-creatinine complex is, how- 
ever, not possible. Accordingly, creatinine is not phos- 
phorylated in the forward reaction. The difference 
between creatine and creatinine or their N-phospho- 
rylated derivatives, respectively, depends on the 
intact or lactonized carboxyl function. It can be con- 
cluded that the carboxyl group is significant for the 
steric orientation and activation of the guanidino 
compound at the active site of creatine kinase. In 
experiments of McLaughlin and Cohn [3] l-carboxy- 
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Fig. 3. Replot of intercepts from fig. 1 versus creatinine phos- 
phate concentration. 
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Fig. 2. Noncompetitive inhibition of the initial velocity of the creatine kinase reaction by creatinine phosphate with ADP as 
variable substrate. pH 7.05, T= 3O”C, creatine phosphate concentration 11.44 mM. (0) no added creatinine phosphate, (o) 
5.72 creatinine phosphate. (Means of three experiments.) 
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Fig. 4. Competitive inhibition of the initial velocity of the creatine kinase activity in heart muscle homogenate of rabbit with 
creatine phosphate as variable substrate. pH 7.05, T = 3O”C, ADP concentration 0.5 mM. (0) no added creatinine phosphate, 
(o) 5.72 mM, (4) 11.44 mM creatinine phosphate. (Means of three experiments.) 
methyl-2-iminoimid~olidine was the most reactive 
analog of creatine in the forward reaction. This is in 
accordance with the expectation that the five-mem- 
bered ring analog inhibited the reverse reaction, 
Although the kinetics of the inhibition was of compe- 
titive type in relation to CP the inhibition has to be 
understood as product inhibition. Inverse to the 
inhibition type of creatinine phosphate the magne- 
sium-nucleotide complexes MgCDP, MgUDP and 
MgGDP caused competitive inhibition with respect 
to MgADP and noncompetitive inhibition with 
respect o CP [2]. 
The results found with highly purified creatine 
kinase of skeletal muscle were proved by those obtain- 
ed with creatine kinase activity of rabbit heart homo- 
genates. The creatine kinase activity in the homoge- 
nates was also competitively inhibited by creatinine 
phosphate (fig. 4). In experiments with heartlung 
preparations of the rabbit the addition of creatinine 
phosphate suggests an in vivo inhibition of creatine 
kinase [ 141. The hearts became dilated and insuffi- 
cient. Metabolite determinations showed a dimin- 
90 
ished ATP content and a normal or even increased 
CP content. Until now in investigations of muscle 
metabolism the unspecific sulfhydryl reagent 1 -fluoro- 
24 dinitrobenzene was used for inhibition of creatine 
kinase [15-l 71. In further investigations the use of 
creatinine phosphate can be very helpful because of 
its great specificity for this essential reaction in muscle 
metabolism. 
4. Summary 
Creatinine phosphate was shown to be no sub- 
strate of purified creatine kinase from skeletal muscle 
or of creatine kinase in heart muscle homogenate. It 
was found to be a competitive inhibitor with respect 
to creatine phosphate and a noncompetitive inhibitor 
with respect o ADP. 
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